z-logo
Premium
Experimental design approach for the removal of the antidiabetic drug, metformin at a high concentration by photocatalytic processes
Author(s) -
EstradaArriaga Edson Baltazar,
GarcíaSánchez Liliana,
FalcónRojas Axel
Publication year - 2021
Publication title -
water and environment journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 37
eISSN - 1747-6593
pISSN - 1747-6585
DOI - 10.1111/wej.12668
Subject(s) - photocatalysis , metformin , catalysis , reaction rate constant , chemistry , nuclear chemistry , pharmacology , kinetics , biochemistry , endocrinology , medicine , diabetes mellitus , physics , quantum mechanics
The metformin, is an emerging contaminant and one of the most consumed drugs in the world that has a high power of endocrine disruption across species in the ecosystem. The focus of this study was to determine the best photocatalytic processes through the study of TiO 2 ‐based photocatalytic, photo–Fenton and photo–ferrioxalate reactions for the metformin removal. The experimental results demonstrated that a high removal of metformin is obtained using TiO 2 ‐based photocatalytic (97 %), followed by photo–Fenton (66%) and photo–ferrioxalate (41%). The zero‐order rate constant (k) for TiO 2 ‐based photocatalytic, photo–Fenton and photo–ferrioxalate reaction was 2.36, 1.95 and 1.92 mg/L.min, respectively. The metformin was transformed into NH 4 + ‐N, NO 2 − ‐N and NO 3 − ‐N. According to results obtained, the proposed Box–Behnken experimental design can be used in photocatalytic processes to obtain the optimum conditions of the significant variables (H 2 O 2 concentration, catalytic concentration, pH and reaction time) for removal of metformin in a few runs.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom